XEMPLIFI DBM PLUS 8103.0210S

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2018-01-02 for XEMPLIFI DBM PLUS 8103.0210S manufactured by Allosource.

Event Text Entries

[96218116] According to the report from the distributor, an infection had materialized 3 weeks post surgery. The tissue based medical device is aseptically processed, freeze dried, and terminally sterilized via electron beam irradiation. Ninety-two (92) total tissue lots were produced from donor 166147: 62 device lots, 19 skin grafts, 2 bone grafts, 9 soft tissue grafts. Eighty-one (81) total lots were distributed: 58 device lots were distributed, 4 used as qc samples; all 19 skin lots were distributed; all 2 bone lots were distributed; 2 soft tissue lots were distributed, and 7 were quarantined. Two lots of tissue based device were implanted into the patient associated with this adverse event (b)(4). Allosource has received no additional reports of adverse reactions or adverse events associated with the other 79 distributed lots. Ninety-one (91) total tissue lots were produced from donor 165433: 54 device lots, 28 skin grafts, 9 soft tissue grafts. Seventy-seven (77) total lots were distributed: 48 device lots, 4 used as qc samples, 2 discarded prior to distribution; 26 skin lots were distributed, and 2 were quarantined; 3 soft tissue lots were distributed, and 6 were quarantined. One lot of tissue based device was implanted into the patient associated with this adverse event (b)(4). Allosource has received no additional reports of adverse reactions or adverse events associated with the other 76 distributed lots.
Patient Sequence No: 1, Text Type: N, H10


[96218117] Three lots of xemplifi dbm plus putty 10 cc, from two donors, manufactured by allosource were implanted into a patient on (b)(6) 2017. On 8/17/2017 the surgeon notified the private label distributor that he was worried that the patient got a staph infection from the "bone graft". Allosource received notification of the incident on (b)(6) 2017. The three lots of tissue based medical devices remain in the patient. No additional information has been received from the surgeon to date. Three separate adverse event reports are being submitted for the event associated with this patient: 3000215346-2017-00006, 3000215346-2017-00007.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3000215346-2017-00008
MDR Report Key7158026
Report SourceDISTRIBUTOR
Date Received2018-01-02
Date of Report2017-09-28
Date of Event2017-08-17
Date Mfgr Received2017-08-30
Device Manufacturer Date2017-05-08
Date Added to Maude2018-01-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. TREVOR WRIGHT
Manufacturer Street6278 S. TROY CIRCLE
Manufacturer CityCENTENNIAL CO 80111
Manufacturer CountryUS
Manufacturer Postal80111
Manufacturer Phone7208734733
Manufacturer G1ALLOSOURCE
Manufacturer Street6278 S. TROY CIRCLE
Manufacturer CityCENTENNIAL CO 80111
Manufacturer CountryUS
Manufacturer Postal Code80111
Single Use3
Remedial ActionNO
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameXEMPLIFI DBM PLUS
Generic NameBONE VOID FILLLER
Product CodeMBP
Date Received2018-01-02
Model Number8103.0210S
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerALLOSOURCE
Manufacturer Address6278 S. TROY CIRCLE CENTENNIAL CO 80111 US 80111


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-01-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.